Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa
Clinical trial NCT06238856 · COMPLETED
Trial details
- NCT number
- NCT06238856
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-12
- Primary completion
- 2005-02-08
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.